Evidence map›Paper›PMID 28369058›Full record

Observational studyPLoS genetics2017

Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.

Lasse Folkersen, Eric Fauman, Maria Sabater-Lleal, Rona J Strawbridge, Mattias Frånberg, Bengt Sennblad, Damiano Baldassarre, Fabrizio Veglia, Steve E Humphries, Rainer Rauramaa and 24 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 234 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
234citing papers in PubMed, 9 pooled it
17.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

234 citing papers in PubMed, 9 syntheses or guidelines pooled it, 367 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

174 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 13 institutions in 8 countries.

Lasse FolkersenDepartment of Systems Biology, Technical University of Denmark, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-0708-9530
Eric FaumanPfizer Worldwide Research & Development, Cambridge, Massachusetts, United States of America.ORCID http://orcid.org/0000-0002-9739-0249
Maria Sabater-LlealCardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-0128-379X
Rona J StrawbridgeCardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Mattias FrånbergCardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Bengt SennbladCardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Damiano BaldassarreDipartimento di Scienze Farmacologiche e Biomolecolari, Università di Milano, Milan, Italy.ORCID http://orcid.org/0000-0002-2766-8882
Fabrizio VegliaCentro Cardiologico Monzino, IRCCS, Milan, Italy.
Steve E HumphriesBritish Heart Foundation Laboratories, University College of London, Department of Medicine, Rayne Building, London, United Kingdom.ORCID http://orcid.org/0000-0002-8221-6547
Rainer RauramaaFoundation for Research in Health Exercise and Nutrition, Kuopio Research Institute of Exercise Medicine, Kuopio, Finland.
Ulf de FaireDivision of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden.
Andries J SmitDepartment of Medicine, University Medical Center Groningen, Groningen, the Netherlands.
Philippe GiralAssistance Publique - Hopitaux de Paris; Service Endocrinologie-Metabolisme, Groupe Hôpitalier Pitie-Salpetriere, Unités de Prévention Cardiovasculaire, Paris, France.
Sudhir KurlInstitute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio Campus, Kuopio, Finland.
Elmo MannarinoInternal Medicine, Angiology and Arteriosclerosis Diseases, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy.
Stefan EnrothDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory Uppsala, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-5056-9137
Åsa JohanssonDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory Uppsala, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-2915-4498
Sofia Bosdotter EnrothDepartment of Internal Medicine, Uppsala University Hospital, Uppsala, Sweden.
Stefan GustafssonDepartment of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Lars LindDepartment of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Cecilia LindgrenWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Andrew P MorrisDepartment of Biostatistics, University of Liverpool, Liverpool, United Kingdom.
Vilmantas GiedraitisWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Angela SilveiraCardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Anders Franco-CerecedaCardiothoracic Surgery Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Elena TremoliDipartimento di Scienze Farmacologiche e Biomolecolari, Università di Milano, Milan, Italy.
IMPROVE study group
Ulf GyllenstenDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory Uppsala, Uppsala University, Uppsala, Sweden.
Erik IngelssonDepartment of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Søren BrunakDepartment of Systems Biology, Technical University of Denmark, Copenhagen, Denmark.
Per ErikssonCardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-5635-2692
Daniel ZiemekPfizer Worldwide Research & Development, Cambridge, Massachusetts, United States of America.
Anders HamstenCardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Anders MälarstigCardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-2608-1358
Karolinska Institutet · SEUppsala University · SEPfizer (United States) · USCentre for Human Genetics · GBUniversity of Milan · ITBritish Heart Foundation · GBCentro Cardiologico Monzino · ITKarolinska University Hospital · SESorbonne Université · FRUniversity Medical Center Groningen · NLUniversity of Eastern Finland · FIUniversity of Liverpool · GBUniversity of Perugia · IT

Funding

Causal associations of circulating biomarkers with cardiovascular diseaseR01HL135313 · NHLBI · STANFORD UNIVERSITY · PI INGELSSON, ERIK · 2017 to 2019
$1.6M
British Heart Foundation RG/08/008/25291NHLBI NIH HHS R01 HL135313Wellcome Trust
6 · The paper itself

Abstract

Recent advances in highly multiplexed immunoassays have allowed systematic large-scale measurement of hundreds of plasma proteins in large cohort studies. In combination with genotyping, such studies offer the prospect to 1) identify mechanisms involved with regulation of protein expression in plasma, and 2) determine whether the plasma proteins are likely to be causally implicated in disease. We report here the results of genome-wide association (GWA) studies of 83 proteins considered relevant to cardiovascular disease (CVD), measured in 3,394 individuals with multiple CVD risk factors. We identified 79 genome-wide significant (p<5e-8) association signals, 55 of which replicated at P<0.0007 in separate validation studies (n = 2,639 individuals). Using automated text mining, manual curation, and network-based methods incorporating information on expression quantitative trait loci (eQTL), we propose plausible causal mechanisms for 25 trans-acting loci, including a potential post-translational regulation of stem cell factor by matrix metalloproteinase 9 and receptor-ligand pairs such as RANK-RANK ligand. Using public GWA study data, we further evaluate all 79 loci for their causal effect on coronary artery disease, and highlight several potentially causal associations. Overall, a majority of the plasma proteins studied showed evidence of regulation at the genetic level. Our results enable future studies of the causal architecture of human disease, which in turn should aid discovery of new drug targets.

Indexed as

Quantitative Trait LociBiomarkersBlood ProteinsCardiovascular DiseasesCoronary Artery DiseaseFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMaleBiomarkersBlood Proteins

Identifiers

PMID28369058
PMCPMC5393901
OpenAlexW2605261164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.